Erick J. Lucera
CFO, Principal Financial Officer & Principal Accounting Officer and TreasurerMr. Erick J. Lucera, C.F.A., C.P.A., is Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer and Treasurer of Dyne Therapeutics, Inc. from March 31, 2025. Mr. Lucera served as Chief Financial Officer and Executive Vice President at Editas Medicine, Inc. since May 17, 2023 until March 28, 2025. He had been an Independent Director of Bone Biologics Corporation since October 2021 until December 27, 2023. He serves as an Independent Director at SAB Biotherapeutics, Inc. since April 04, 2023. Mr. Lucera joined the SAB Biotherapeutics, Inc. on April 04, 2023. He served as Chief Financial Officer at AVEO Pharmaceuticals, Inc. since January 06, 2020 until February 2023. Mr. Lucera served as Chief Executive Officer and Portfolio Manager of Triathlon Fund Management, LLC. Mr. Lucera served as Chief Financial Officer of Valeritas Holdings, Inc. since August 29, 2016 until December 2019 and served as its Secretary and served as its Executive Vice President until December 2019. Mr. Lucera served as the Chief Financial Officer of Viventia Bio Inc. from May 2015 to August 2016 and served as its Secretary and Treasurer from September 2015 to August 2016. He served as Trustee at Shakespeare & Company, Inc. since December 2018 until 2022. Mr. Lucera served as a Vice President of Corporate Development at Aratana Therapeutics, Inc. from January 24, 2013 to April 2015. He has diverse experience in the healthcare public equity markets. He has financial, operational and investment experience in the biotechnology and medical device industries. Prior to joining Aratana, he spent few years as Vice President and Healthcare Analyst at Eaton Vance Investment Managers. Mr. Lucera served as a Vice President of Corporate Development at CHF Solution (formerly Sunshine Heart, Inc.,) a global medical device company, from March 2012 to December 2012. Prior to that, he served as a Vice President of Equity Research at Eaton Vance Corp., an investment management firm, from 2008 to 2011. He Partnered the Triathlon Life Sciences Fund, a hedge fund focused on the healthcare industry, in 2002 with Waterhouse Capital/Associates, an investment firm, in a joint venture, where he served as Managing Member and Portfolio Manager from 2004 to 2007. He served as a Senior Vice President, Principal and Head of Healthcare Research at Independence Investment Associates Inc., an institutional investment firm, from 1995 to 2004. From 2004 to 2007, Mr. Lucera served as a Portfolio Manager at Intrepid Capital, where he successfully constructed and managed a portfolio constructed across biotech, pharmaceutical and device and service companies. Prior to that, he held various leadership positions at Price Waterhouse & Co., Independence Investments, including Head of Healthcare Research. He began his career as a staff auditor and accountant at PwC. He has been an Independent Director of Beyond Air, Inc. (formerly known as AIT Therapeutics, Inc.) since August 10, 2017. Mr. Lucera holds a CPH in Public Health from Harvard University in 2001, an M.S. in Quantitative Finance from The Wallace E. Carroll Graduate School of Management of Boston College in 1999, an MBA from Indiana University Bloomington in 1995 and a B.S. in Accounting from Lerner College of Business and Economics of University of Delaware. Mr. Lucera has obtained CFA and CMA designations and received a CPA (inactive) from the Commonwealth of Pennsylvania.
Positions
- Company NameDyne Therapeutics, Inc.Stock CodeDYNPositionCFO, Principal Financial Officer & Principal Accounting Officer and TreasurerColleagues
- JGJohn G. CoxCEO, President & Director
- JPJason P. RhodesIndependent Chairman
- EJErick J. LuceraCFO, Principal Financial Officer & Principal Accounting Officer and Treasurer
- OBOxana BeskrovnayaChief Innovation Officer
- JFJohanna Friedl-NadererChief Commercial Officer
- DKDouglas KerrHead of Research & Development and Chief Medical Officer
- DKDirk KerstenIndependent Director
- DCDavid Charles LubnerIndependent Director
- EMEdward M. HurwitzIndependent Director
- Company NameBeyond Air, Inc.Stock CodeXAIRPositionIndependent DirectorColleagues
- RSRobert Scott GoodmanCEO & Director
- RFRobert F. CareyIndependent Chairman of the Board
- DJDaniel J. MoorheadChief Financial Officer
- MAMichael A. GaulChief Operating Officer
- DDDenton DrewellPrincipal Accounting Officer & Controller
- ARAndrew R. ColinSenior Medical Director Global Clinical Leadership & Member of Scientific Advisory Board
- EJErick J. LuceraIndependent Director
- YLYoori LeeIndependent Director
- Company NameSAB Biotherapeutics, Inc.Stock CodeSABSPositionIndependent DirectorColleagues
- SJSamuel J. ReichCEO & Director
- DSDavid Scott ZaccardelliIndependent Chair of the Board
- EJEddie Joe SullivanCo-Founder, President & Director
- LTLucy ToExecutive VP & CFO
- CBChristoph BauschExecutive VP & COO
- AKAlexandra KropotovaExecutive VP & Chief Medical Officer
- DCDavid Charles LinkIndependent Vice Chairman
